J.L. Hayward

6.8k total citations · 2 hit papers
113 papers, 5.4k citations indexed

About

J.L. Hayward is a scholar working on Oncology, Genetics and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, J.L. Hayward has authored 113 papers receiving a total of 5.4k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Oncology, 44 papers in Genetics and 29 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in J.L. Hayward's work include Estrogen and related hormone effects (43 papers), Cancer Risks and Factors (28 papers) and Breast Cancer Treatment Studies (26 papers). J.L. Hayward is often cited by papers focused on Estrogen and related hormone effects (43 papers), Cancer Risks and Factors (28 papers) and Breast Cancer Treatment Studies (26 papers). J.L. Hayward collaborates with scholars based in United Kingdom, Japan and Netherlands. J.L. Hayward's co-authors include R.D. Rubens, R.D. Bulbrook, S Kumaoka, Paul P. Carbone, A Segaloff, R.D. Bulbrook, Jean-Claude Heuson, Rosemary R. Millis, C.C. Spicer and Ian S. Fentiman and has published in prestigious journals such as The Lancet, American Journal of Clinical Nutrition and Cancer.

In The Last Decade

J.L. Hayward

111 papers receiving 4.9k citations

Hit Papers

Assessment of response to therapy in advanced breast cancer 1977 2026 1993 2009 1977 1977 200 400 600

Peers

J.L. Hayward
A P M Forrest United Kingdom
T.J. Powles United Kingdom
Olof H. Pearson United States
Maureen Kavanah United States
Hans-Jörg Senn Switzerland
Trevor J. Powles United Kingdom
A. Costa Italy
Harold A. Harvey United States
A P M Forrest United Kingdom
J.L. Hayward
Citations per year, relative to J.L. Hayward J.L. Hayward (= 1×) peers A P M Forrest

Countries citing papers authored by J.L. Hayward

Since Specialization
Citations

This map shows the geographic impact of J.L. Hayward's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J.L. Hayward with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J.L. Hayward more than expected).

Fields of papers citing papers by J.L. Hayward

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J.L. Hayward. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J.L. Hayward. The network helps show where J.L. Hayward may publish in the future.

Co-authorship network of co-authors of J.L. Hayward

This figure shows the co-authorship network connecting the top 25 collaborators of J.L. Hayward. A scholar is included among the top collaborators of J.L. Hayward based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J.L. Hayward. J.L. Hayward is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Stavola, Bianca De, R.D. Bulbrook, DS Allen, et al.. (1992). Relationship of Blood Prolactin Levels and the Risk of Subsequent Breast Cancer. International Journal of Epidemiology. 21(2). 214–221. 58 indexed citations
2.
Chaudary, M.A., J.L. Hayward, R.D. Bulbrook, et al.. (1991). A comparison of epidemiological characteristics in breast cancer patients and normal women in Great Britain and Japan: Results of a prospective study. Breast Cancer Research and Treatment. 18(S1). S19–S22. 13 indexed citations
3.
Gravelle, I. H., et al.. (1991). A comparison of mammographic parenchymal patterns in premenopausal Japanese and British women. Breast Cancer Research and Treatment. 18(S1). S93–S95. 19 indexed citations
4.
Stavola, Bianca De, I. H. Gravelle, DS Allen, et al.. (1990). Relationship of Mammographic Parenchymal Patterns with Breast Cancer Risk Factors and Risk of Breast Cancer in a Prospective Study. International Journal of Epidemiology. 19(2). 247–254. 55 indexed citations
5.
Rubens, R.D., Harry Bartelink, E Engelsman, et al.. (1989). Locally advanced breast cancer: The contribution of cytotoxic and endocrine treatment to radiotherapy. European Journal of Cancer and Clinical Oncology. 25(4). 667–678. 73 indexed citations
6.
Wang, D.Y., Bianca De Stavola, R.D. Bulbrook, et al.. (1988). The permanent effect of reproductive events on blood prolactin levels and its relation to breast cancer risk: a population study of postmenopausal women. European Journal of Cancer and Clinical Oncology. 24(7). 1225–1231. 63 indexed citations
7.
Wang, D.Y., Bianca De Stavola, R.D. Bulbrook, et al.. (1987). The relationship between blood prolactin levels and risk of breast cancer in premenopausal women. European Journal of Cancer and Clinical Oncology. 23(10). 1541–1548. 43 indexed citations
8.
Fentiman, Ian S., J.L. Hayward, Rosemary R. Millis, & Jack Cuzick. (1984). Which patients are cured of breast cancer?. BMJ. 289(6457). 1537.3–1538. 1 indexed citations
9.
Fentiman, Ian S., Jack Cuzick, Rosemary R. Millis, & J.L. Hayward. (1984). Which patients are cured of breast cancer?. BMJ. 289(6452). 1108–1111. 33 indexed citations
10.
Rubens, R.D. & J.L. Hayward. (1980). Estrogen receptors and response to endocrine therapy and cytotoxic chemotherapy in advanced breast cancer. Cancer. 46(S12). 2922–2924. 28 indexed citations
11.
Thomas, B.S., R.D. Bulbrook, & J.L. Hayward. (1967). Urinary steroid assays and response to endocrine ablation.. BMJ. 3(5564). 523–524. 10 indexed citations
12.
Bulbrook, R.D. & J.L. Hayward. (1967). ABNORMAL URINARY STEROID EXCRETION AND SUBSEQUENT BREAST CANCER. The Lancet. 289(7489). 519–522. 89 indexed citations
13.
Falconer, M. A., et al.. (1966). THE TIMING OF ADRENALECTOMY AND OF HYPOPHYSECTOMY IN THE TREATMENT OF ADVANCED BREAST CANCER. The Lancet. 287(7442). 827–830. 22 indexed citations
14.
Hayward, J.L. & R.D. Bulbrook. (1965). The value of urinary steroid estimations in the prediction of response to adrenalectomy or hypophysectomy.. PubMed. 25(7). 1129–34. 8 indexed citations
15.
Bulbrook, R.D., J.L. Hayward, & B.S. Thomas. (1964). THE RELATION BETWEEN THE URINARY 17-HYDROXYCORTICOSTEROIDS AND 11-DEOXY-17-OXOSTEROIDS AND THE FATE OF PATIENTS AFTER MASTECTOMY. The Lancet. 283(7340). 945–947. 43 indexed citations
16.
Bulbrook, R.D., J.L. Hayward, C.C. Spicer, & B.S. Thomas. (1962). A COMPARISON BETWEEN THE URINARY STEROID EXCRETION OF NORMAL WOMEN AND WOMEN WITH ADVANCED BREAST CANCER. The Lancet. 280(7268). 1235–1237. 68 indexed citations
17.
Bulbrook, R.D., J.L. Hayward, C.C. Spicer, & B.S. Thomas. (1962). ABNORMAL EXCRETION OF URINARY STEROIDS BY WOMEN WITH EARLY BREAST CANCER. The Lancet. 280(7268). 1238–1240. 85 indexed citations
18.
Bulbrook, R.D., F. C. Greenwood, & J.L. Hayward. (1960). SELECTION OF BREAST-CANCER PATIENTS FOR ADRENALECTOMY OR HYPOPHYSECTOMY BY DETERMINATION OF URINARY 17-HYDROXYCORTICOSTEROIDS AND ÆTIOCHOLANOLONE. The Lancet. 275(7135). 1154–1157. 125 indexed citations
19.
Atkins, H. J. B., et al.. (1960). ADRENALECTOMY AND HYPOPHYSECTOMY FOR ADVANCED CANCER OF THE BREAST. The Lancet. 275(7135). 1148–1153. 57 indexed citations
20.
Hayward, J.L., et al.. (1957). THE EXCRETION OF 17-KETOSTEROIDS IN THE URINE OF PATIENTS WITH GENERALISED CARCINOMATOSIS SECONDARY TO CARCINOMA OF THE BREAST. The Lancet. 269(6967). 496–499. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026